Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

• Status: Terminated
• Trial end date: 2008-08-01

Summary

The purpose of this study is to determine:

1. whether there is a difference between insulin aspart and insulin lispro in continuous insulin pump therapy

2. whether duration of the insulin infusion set placement effect blood sugar control if the infusion set is in place for longer then 72-96 hours

• Phase: N/A

Details

• Lead Sponsor: Joslin Diabetes Center
• Collaborator: Novo Nordisk A/S
• Treatments: Insulin; Insulin Aspart; Insulin degludec, insulin aspart drug combination; Insulin Lispro; Insulin, Globin Zinc; Insulin, Long-Acting